Literature DB >> 3259832

The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia.

V Dilsizian1, R O Bonow, R O Cannon, C M Tracy, D F Vitale, C L McIntosh, R E Clark, S L Bacharach, M V Green.   

Abstract

Successful coronary artery bypass grafting (CABG) improves exercise-induced left ventricular (LV) dysfunction in patients with coronary artery disease (CAD), but its potential for improving resting LV function remains controversial. To assess the influence of CABG on LV function at rest, 31 CAD patients without previous myocardial infarction were studied before and 6 months after CABG by radionuclide angiography after all cardiac medicines were withdrawn. No patient had angina or ischemic electrocardiographic changes at rest. In 27 patients with patent bypass grafts, CABG significantly increased LV ejection fraction during exercise (47 +/- 11% before to 63 +/- 9% after operation, p less than 0.001), indicating reduction in exercise-induced LV ischemia. Moreover, LV ejection fraction at rest also increased (55 +/- 9 to 60 +/- 8%, p less than 0.001), with 20 of 27 patients manifesting an increase compared with preoperative values. Eleven of these 20 patients had apparently normal LV function at rest (ejection fraction and regional wall motion) before CABG. LV regional ejection fraction was computed by dividing the LV region of interest into 20 sectors. Regional analysis indicated that improved ejection fraction at rest after CABG occurred in regions developing ischemia during exercise before CABG. In 4 patients with occluded grafts, the ejection fraction at rest was unchanged by CABG globally (59 +/- 8 to 58 +/- 9%, difference not significant) and regionally. Thus, LV global and regional function at rest improved after successful CABG, even in patients with normal global LV ejection fraction and no visually detectable wall motion abnormality before surgery.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259832     DOI: 10.1016/0002-9149(88)91164-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Subparsec-scale structure and evolution of Centaurus A (NGC5128).

Authors:  D L Jauncey; S J Tingay; R A Preston; J E Reynolds; J E Lovell; P M McCulloch; A K Tzioumis; M E Costa; D W Murphy; D L Meier; D L Jones; S W Amy; J D Biggs; D G Blair; R W Clay; P G Edwards; S P Ellingsen; R H Ferris; R G Gough; P Harbison; P A Jones; E A King; A J Kemball; V Migenes; G D Nicolson; M W Sinclair; T Van Ommen; R M Wark; G L White
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 2.  The historical and conceptual evolution of radionuclide assessment of myocardial viability.

Authors:  James E Udelson; Robert O Bonow; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

Review 3.  Radionuclide techniques for the assessment of myocardial viability.

Authors:  E Skoufis; A I McGhie
Journal:  Tex Heart Inst J       Date:  1998

4.  Prediction of long-term effects of revascularization on regional and global left ventricular function by dobutamine echocardiography and rest Tl-201 imaging alone and in combination in patients with chronic coronary artery disease.

Authors:  Santo Dellegrottaglie; Pasquale Perrone-Filardi; Leonardo Pace; Mariella Prastaro; Anna Maria Della Morte; Maria Paola Ponticelli; Federico Piscione; Giovanni Storto; Giuseppe De Luca; Marco Salvatore; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

5.  F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.

Authors:  J Fitzgerald; J A Parker; P G Danias
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

6.  Technetium 99m furifosmin regional myocardial uptake in patients with previous myocardial infarction: relation to thallium-201 activity and left ventricular function.

Authors:  A Cuocolo; G Rubini; W Acampa; E Nicolai; L Florimonte; G DiGiovine; A D'Addabbo; M Salvatore
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

7.  Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.

Authors:  A R Galassi; C Tamburino; R Grassi; R Foti; C Mammana; A Virgilio; G Licciardello; S Musumeci; G Giuffrida
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

8.  Left ventricular dysfunction in coronary artery disease: comparison between rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile cardiac imaging.

Authors:  S Maurea; A Cuocolo; L Pace; E Nicolai; A Nappi; M Imbriaco; B Trimarco; M Salvatore
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

9.  An estimate of the prevalence of reversible left ventricular dysfunction in patients referred for coronary artery bypass surgery.

Authors:  T F Christian; T D Miller; D O Hodge; T A Orszulak; R J Gibbons
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

Review 10.  Left ventricular dysfunction due to stunning and hibernation in patients.

Authors:  R Ferrari; G La Canna; R Giubbini; E Milan; C Ceconi; F de Giuli; P Berra; O Alfieri; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.